Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
AZD5004 (ECC5004) Datasheet
AZD5004 / Eccogene, AstraZeneca
Azd5004 – Application in Therapy and Current Clinical Research
Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 ...
Estudio sobre los efectos de AZD5004 en adultos con obesidad o ...
AstraZeneca Presents Promising Early Data on Oral GLP-1 Agonist AZD5004 ...
AstraZeneca's Oral GLP-1 Agonist AZD5004 Shows Promise in Phase I ...
Structure of AZD3582. | Download Scientific Diagram
AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New ...
Chemical structure of AZD | Download Scientific Diagram
Molecular structure of AZD1305. | Download Scientific Diagram
Chemical structure of AZD7325 | Download Scientific Diagram
Structure of AZD2563. | Download Scientific Diagram
Chemical structure of AZ 4 Pd with four azobenzene groups connected by ...
ECC5004 | GLP-1 agonist | Probechem Biochemicals
百亿美元市场！领路者阿斯利康两手抓：奥拉帕利再获新适应症，下一代产品多款布局
AstraZeneca: Strong Growth Potential And Market Volatility Offer ...
#Wikimole Compounds – Caltag Medsystems
Chemical structures of synthetic drugs used for treating obesity ...
Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and ...
GLP-1 receptor agonist 14 | C48H46F2N10O5 | CID 167350327 - PubChem
elecoglipron (AZD5004) / Eccogene, AstraZeneca
Non-clinical and first-in-human characterization of ECC5004/AZD5004, a ...
阿斯利康的AZD5004、罗氏的CT-996与Terns的TERN-601均展现出较好的I期临床数据 - 2025年09月 - - 小牛行研
Computational Study on New Natural Compound Inhibitors of Pyruvate ...
阿斯利康：GLP-1/GCG+Amylin启动减重2b期临床
AstraZeneca’s AZD5004: A Power Move in Obesity Medicine
ECC5004(AZD5004) GLP-1 Receptor Agonist | Selleck Chemicals
AZ·에코진, 경구용 GLP-1 후보 ‘AZD5004’ 中 임상1b상 돌입…첫 환자 투약
Eccogene首次在中國進行AZD5004臨床試驗 - ss future
Eccogene Announces Positive Topline Results from Phase 1b Trial of ...
Eccogene Receives Milestone Payment of $60 Million from AstraZeneca ...
Azidothymidine, Zidovudine, Cpd S, AZT, BW-A509U, AZTEC, Retrovir-药物合成数据库
4周减重九斤！阿斯利康披露口服小分子GLP-1药物的最新数据，超18亿美元合作有望兑现_腾讯新闻
AZ, 올해 '먹는 비만약' 임상2b상 추진…"비만보다 체중관리 초점"
Structure, biochemical, and cellular activity of AZD2014. A, chemical ...
AZD0780 | Inhibitor | TargetMol
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a ...
Small-molecule Articles | Smolecule
Small molecules shield mice against hearing loss
Structures and atom numbering of the studied compounds, and the ...
AZD0516 | Anti-STEAP2 ADC | MedChemExpress
AZD-5462 | Selleck Chemicals
A Study to Investigate Multiple Ascending Doses and Relative ...
潜在重磅小分子GLP-1新药在华获批临床！阿斯利康超20亿美元合作开发
AZD1656 | Carbohydrate Metabolism activator | CAS 919783-22-5 | Selleck
Schematic of AZD0466 drug substance and drug product process. A ...
AZD0156 | ATM Inhibitor | CAS 1821428-35-6 | Selleck Chemicals
Obesity News Recap ~ WC (04/11/2024) 💡 🌿 SJLife Sciences 🌿 ...
潜在5款重磅下一代GLP-1疗法|糖尿病|阿斯利康|临床试验_新浪新闻
AZD9574 (Palacaparib) | PARP1 Inhibitor | CAS 2756333-39-6 | Selleck ...
Optimized structures for 4c and 4d azaindazole derivatives and their ...
5-Azido-4-dimethylamino-1-methyl-1,2,4-triazolium Hexafluoridophosphate ...
AZDye488-Azide, Azide-containing Fluorescent Dyes - Jena Bioscience
Schematic representation of the AZD2 molecular structure. | Download ...
